当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第26期
编号:11682996
乳腺癌患者COX-2 mRNA 表达与雌激素受体水平的相关性研究(2)
http://www.100md.com 2008年11月5日 《中国实用医药》 2008年第26期
     [4] Clark GM,Osborne CK,Levitt D,et al.Telomerase activity and survival of patients with node-positive breast cancer.J Natl Cancer Inst,1997,89(24):1874-1881.

    [5] Liu CH,Chang SH,Narko K,et al.Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.J Biol Chem,2001,276(21):18563.

    [6] Sivula A,Talvensaari-Mattila A,Lundin J,et al.Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.Breast Cancer Res Treat,2005,89(3):215.

    [7] Harris RE,Alshafie GA,Abou Issa H,et al.Chemoprevention of breast cancer in rats by celecoxib,a cyxlooxygenase 2 inhibitor.Cancer Res,2000,60(8):2101.

    [8] Guo GL,Yao ZX,Wu J.The clinical significance of exp ression of cyclooxygenase-2 gene in breast cancer.Zhonghua Yi Xue Za Zhi,2003, 83(19):1661-1664.

    [9] Harris RE,Beebe-Donk J,Alshafie GA.Reduction in the risk of human breast cancer by selective cyclooxygenase-2(COX-2)inhibitors.BMC Cancer,2006,6(1):27.

    [10] Shim V,Gauthier ML,Sudilovsky D,et al.Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium.Cancer Res,2003,63(10):2347., 百拇医药(张 慧 鲍慧铮)
上一页1 2